Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 15;3(3):CD004655.
doi: 10.1002/14651858.CD004655.pub3.

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency

Affiliations

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency

Haiyan Wang et al. Cochrane Database Syst Rev. .

Abstract

Background: Vitamin B12 deficiency is common, and the incidence increases with age. Most people with vitamin B12 deficiency are treated in primary care with intramuscular (IM) vitamin B12. Doctors may not be prescribing oral vitamin B12 formulations because they may be unaware of this option or have concerns regarding its effectiveness.

Objectives: To assess the effects of oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.

Search methods: We searched CENTRAL, MEDLINE, Embase, and LILACS, as well as the WHO ICTRP and ClinicalTrials.gov. The latest search date was 17 July 2017. We applied no language restrictions. We also contacted authors of relevant trials to enquire about other published or unpublished studies and ongoing trials.

Selection criteria: Randomised controlled trials (RCTs) comparing the effect of oral versus IM vitamin B12 for vitamin B12 deficiency.

Data collection and analysis: We used standard methodological procedures expected by Cochrane. Our primary outcomes were serum vitamin B12 levels, clinical signs and symptoms of vitamin B12 deficiency, and adverse events. Secondary outcomes were health-related quality of life, acceptability to patients, haemoglobin and mean corpuscular volume, total homocysteine and serum methylmalonic acid levels, and socioeconomic effects. We used GRADE to assess the quality of the evidence for important outcomes. We did not perform meta-analyses due to the small number of included trials and substantial clinical heterogeneity.

Main results: Three RCTs met our inclusion criteria. The trials randomised 153 participants (74 participants to oral vitamin B12 and 79 participants to IM vitamin B12). Treatment duration and follow-up ranged between three and four months. The mean age of participants ranged from 38.6 to 72 years. The treatment frequency and daily dose of vitamin B12 in the oral and IM groups varied among trials. Only one trial had low or unclear risk of bias across all domains and outcome measures. Two trials reported data for serum vitamin B12 levels. The overall quality of evidence for this outcome was low due to serious imprecision (low number of trials and participants). In two trials employing 1000 μg/day oral vitamin B12, there was no clinically relevant difference in vitamin B12 levels when compared with IM vitamin B12. One trial used 2000 μg/day vitamin B12 and demonstrated a mean difference of 680 pg/mL (95% confidence interval 392.7 to 967.3) in favour of oral vitamin B12. Two trials reported data on adverse events (very low-quality evidence due to risk of performance bias, detection bias, and serious imprecision). One trial stated that no treatment-related adverse events were seen in both the oral and IM vitamin B12 groups. One trial reported that 2 of 30 participants (6.7%) in the oral vitamin B12 group left the trial early due to adverse events. Orally taken vitamin B12 showed lower treatment-associated costs than IM vitamin B12 in one trial (low-quality evidence due to serious imprecision). No trial reported on clinical signs and symptoms of vitamin B12 deficiency, health-related quality of life, or acceptability of the treatment scheme.

Authors' conclusions: Low quality evidence shows oral and IM vitamin B12 having similar effects in terms of normalising serum vitamin B12 levels, but oral treatment costs less. We found very low-quality evidence that oral vitamin B12 appears as safe as IM vitamin B12. Further trials should conduct better randomisation and blinding procedures, recruit more participants, and provide adequate reporting. Future trials should also measure important outcomes such as the clinical signs and symptoms of vitamin B12 deficiency, health related-quality of life, socioeconomic effects, and report adverse events adequately, preferably in a primary care setting.

PubMed Disclaimer

Conflict of interest statement

HYW: none known

LYL: none known.

LLQ: none known.

YNS: none known.

JVA: none known.

THL: none known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies (blank cells indicate that the particular outcome was not measured in some studies).
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study (blank cells indicate that the study did not measure that particular outcome).
1.1
1.1. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 1 Serum vitamin B12 levels.
1.2
1.2. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 2 Number of participants with normalisation of serum vitamin B12 deficiency.
1.3
1.3. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 3 Adverse events.
1.4
1.4. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 4 Haemoglobin.
1.5
1.5. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 5 Mean corpuscular volume.
1.6
1.6. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 6 Total homocysteine.
1.7
1.7. Analysis
Comparison 1 Oral versus intramuscular vitamin B12, Outcome 7 Serum methylmalonic acid.

Update of

Comment in

Similar articles

Cited by

References

References to studies included in this review

Bolaman 2003 {published data only}
    1. Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single‐center, prospective, randomized, open‐label study. Clinical Therapeutics 2003;25(12):3124‐34. - PubMed
Kuzminski 1998 {published data only}
    1. Kuzminski AM, Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92(4):1191‐8. - PubMed
Saraswathy 2012 {published data only}
    1. Saraswathy AR, Dutta A, Simon EG, Chacko A. Randomized open label trial comparing efficacy of oral versus intramuscular vitamin B12 supplementation for treatment of vitamin B12 deficiency. Gastroenterology 2012;142(5 Suppl 1):S216.

References to studies excluded from this review

Aguilar 2004 {published data only}
    1. Aguilar Franco C. Subcutaneous administration of vitamin B12. Atencion Primaria 2004;34:509 (author reply 509). - PMC - PubMed
Andres 2005a {published data only}
    1. Andres E, Affenberger S, Vinzio S, Noel E, Kaltenbach G, Schlienger JL. Cobalamin deficiencies in adults: update of etiologies, clinical manifestations and treatment. Revue de Medecine Interne 2005;26:938‐46. - PubMed
Andres 2005b {published data only}
    1. Andres E, Noel E, Kaltenbach G. Usefulness of oral vitamin B12 therapy in vitamin B12 deficiency related to food‐cobalamin malabsorption: Short and long‐term outcome [1]. European Journal of Internal Medicine 2005;16:218. - PubMed
Andres 2011 {published data only}
    1. Andres E, Mecili M. Oral vitamin B12 therapy. Annals of Surgical Oncology 2011;18 Suppl 3:S196‐8 (author reply S199). - PubMed
Andres 2012 {published data only}
    1. Andres E. Oral cobalamin therapy: It may be perhaps time to propose international recommendations?. Presse Medicale 2012;41:895‐8. - PubMed
Bharath 2015 {published data only}
    1. Bharath V, Hsia CC. Vitamin B12 deficiency presenting as pancytopenia with ring sideroblasts. Blood 2015;126:2255. - PubMed
Bharatwaj 2012 {published data only}
    1. Bharatwaj RS. The problem of cyanocobalamin defeciency in a developing country set‐up and the possible solutions. Journal of Clinical and Diagnostic Research 2012;6:921‐2.
Butler 2006 {published data only}
    1. Butler CC, Vidal‐Alaball J, Cannings‐John R, McCaddon A, Hood K, Papaioannou A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Family Practice 2006;23:279‐85. - PubMed
Castelli 2010 {published data only}
    1. Castelli MC, Friedman K, Sherry J, Brazzillo K, Genoble L, Bhargava P, et al. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open‐label, parallel‐group study. Clinical Therapeutics 2011;33:358‐71. - PubMed
    1. Castelli MC, Wong D, Friedman K, Bhargava P, Riley GM. Normalization of vitamin B12 (B12) levels achieved following 1000 mcg oral Eligen B12 therapy: a clinical study comparing the efficacy and safety of oral B12 therapy versus intramuscular (IM) therapy. FASEB Journal 2010;24:lb325.
Emans 2013 {published data only}
    1. Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, et al. Response to letter by Balta et al. International Journal of Cardiology 2013;169:89‐94. - PubMed
EUCTR 2013‐004835‐60 {published and unpublished data}
    1. Vitamin deficiencies and supplementation in morbidly obese. https://www.clinicaltrialsregister.eu/ctr‐search/trial/2013‐004835‐60/NL (accessed 6 December 2017).
Geisel 2005 {published data only}
    1. Geisel J, Schorr H, Bodis M, Isber S, Hubner U, Knapp JP, et al. The vegetarian lifestyle and DNA methylation. Clinical Chemistry & Laboratory Medicine 2005;43:1164‐9. - PubMed
Haffner 2016 {published data only}
    1. Haffner J. Oral treatment of vitamin B12 deficiency. Tidsskrift for Den Norske Laegeforening 2016;136:108. - PubMed
Houle 2014 {published data only}
    1. Houle SK, Kolber MR, Chuck AW. Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost‐saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors (Provisional abstract). BMJ Open 2014; Vol. 4, issue 5:e004501. - PMC - PubMed
ISRCTN22063938 {published and unpublished data}
    1. Cobalamin deficiency in primary care: a placebo‐controlled, double‐blind, randomized trial. http://www.isrctn.com/ISRCTN22063938 (accessed 6 December 2017).
Kim 2011 {published data only}
    1. Kim HI, Hyung WJ, Song KJ, Choi SH, Kim CB, Noh SH. Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Annals of Surgical Oncology 2011;18:3711‐7. - PubMed
Kolber 2014 {published data only}
    1. Kolber MR, Houle SK. Oral vitamin B12: a cost‐effective alternative. Canadian Family Physician 2014;60:111‐2. - PMC - PubMed
Kripke 2006 {published data only}
    1. Kripke C. Is oral vitamin B12 as effective as intramuscular injection?. American Family Physician 2006;73:65. - PubMed
Leidenmuhler 2013 {published data only}
    1. Shakeri‐Leidenmuhler S, Poglitsch M, Kefurt R, Felberbauer FX, Bohdjalian A, Langer FB, et al. Vitamin B12 substitution after gastric bypass surgery: sublingual or intramuscular?. European Surgery ‐ Acta Chirurgica Austriaca 2013;45(2 Suppl):S4 (O33).
Leon 2013 {published data only}
    1. Leon CA, Georges P, Zaeeter W. Vitamin B12 deficiency. New England Journal of Medicine 2013;368:2041. - PubMed
Lin 2012 {published data only}
    1. Lin J, Kelsberg G, Safranek S. Clinical inquiry: Is high‐dose oral B12 a safe and effective alternative to a B12 injection?. Journal of Family Practice 2012;61:162‐3. - PubMed
Lonn 2006 {published data only}
    1. Lonn E. Dr. Lonn replies. New England Journal of Medicine 2006;355:209‐10.
Masucci 2013 {published data only}
    1. Masucci L, Goeree R. Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis. Ontario Health Technology Assessment Series 2013;13:1‐24. - PMC - PubMed
Metaxas 2013 {published data only}
    1. Metaxas C, Schmutz A, Walter P, Hersberger KE. Oral versus parenteral route of application: the patient's preference. International Journal of Clinical Pharmacy 2013;35(6):1295‐6.
Metaxas 2017 {published data only}
    1. Metaxas C, Mathis D, Jeger C, Hersberger KE, Arnet I, Walter P. Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel‐group trial. Swiss Medical Weekly 2017;147:w14421. - PubMed
NCT00699478 {published and unpublished data}
    1. Oral vitamin B12 administration for vitamin B12 deficiency after total gastrectomy. https://clinicaltrials.gov/ct2/show/NCT00699478 (accessed 6 December 2017).
Pacholok 2013 {published data only}
    1. Pacholok SM. Vitamin B12 deficiency: serious consequences. Pharmacy Times 2013;80(2):1.
Radziwill 2014 {published data only}
    1. Radziwill R. Can a vitamin B12 deficiency in PPI intake be offset by an increased intake of oral B12?. Medizinische Monatsschrift fur Pharmazeuten 2014;37:299. - PubMed
Schijns 2016 {published data only}
    1. Schijns W, Meer van der L, Deden L, Janssen IMC, Berends FJ, Aarts EO. Efficacy of oral versus intramuscular vitamin B12 supplementation following Roux‐en‐Y gastric bypass. Obesity Facts 2016; Vol. 9, issue Suppl 1:PO3.104.
Schloss 2015 {published data only}
    1. Schloss J M, Colosimo M, Airey C, Vitetta L. Chemotherapy‐induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Supportive Care in Cancer 2015;23:1843‐50. - PubMed
Stabler 2015 {published data only}
    1. Stabler SP. Anemias due to essential nutrient deficiencies. World Review of Nutrition & Dietetics 2015;111:164‐8. - PubMed

References to studies awaiting assessment

Ashok 2011 {published data only}
    1. Chacko A. Is vitamin B12 tablets as effective as vitamin B12 injections for the treatment of vitamin B12 deficiency?. Christian Medical College, Vellore India 2011.

References to ongoing studies

EUCTR 2009‐014468‐20‐AT {published and unpublished data}
    1. A prospective comparison of vitamin B12 supplementation after gastric bypass surgery (sublingual vs. intramuscular). https://www.clinicaltrialsregister.eu/ctr‐search/trial/2009‐014468‐20/AT (accessed 6 December 2017).
NCT01476007 {published data only}
    1. Gerencia de Atención Primaria Madrid. Oral/intramuscular B12 to treat cobalamin deficiency. Instituto de Salud Carlos III 2015.
    1. Sanz‐Cuesta T, González‐Escobar P, Riesgo‐Fuertes R, Garrido‐Elustondo S, Cura‐González I, Martín‐Fernández J, et al. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multi‐centre, non‐inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health 2012;12:394. - PMC - PubMed
    1. Área de Investigación. Oral versus intramuscular cobalamin to treat cobalamin deficiency: noninferiority randomised controlled trial, pragmatic and multi‐center in the primary healthcare setting (OB12 project). Consorcio de Apoyo a la Investigación Biomédica en red (CAIBER) 2011.

Additional references

Allen 2009
    1. Allen L. How common is vitamin B‐12 deficiency?. American Journal of Clinical Nutrition 2009;89:693‐6. - PubMed
Andres 2004
    1. Andres E, Loukili NH, Noel E, Kaltenbach G, Ben Abdelgheni M, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. Canadian Medical Association Journal 2004;171(3):251‐9. - PMC - PubMed
Andres 2008
    1. Andres E, Vogel T, Federici L, Zimmer J, Kaltenbach G. Update on oral cyanocobalamin (vitamin B12) treatment in elderly patients. Drugs and Aging 2008;25(11):927‐32. - PubMed
Andres 2009
    1. Andres E, Serraj K, Mecili M, Ciobanu E, Vogel T, Weitten T. Update of oral vitamin B12. Annales d Endocrinologie 2009;70(6):455‐61. - PubMed
Andres 2010
    1. Andres E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opinion on Pharmacotherapy 2010;11(2):249‐56. - PubMed
Anonymous 1991
    1. Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values of the committee on medical aspects of food policy. Report on Health and Social Subjects 1991; Vol. 41:1‐210. - PubMed
Bahadir 2015
    1. Bahadir A, Reis PG, Erduran E. Oral vitamin B12 treatment is effective for children with nutritional vitamin B12 deficiency. Journal of Paediatrics and Child Health 2014;50(9):721‐5. - PubMed
Berlin 1968
    1. Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Medica Scandinavica 1968;184(4):247‐58. - PubMed
Berlin 1978
    1. Berlin R, Berlin H, Brante G, Pilbrant A. Vitamin B12 body stores during oral and parenteral treatment of pernicious anaemia. Acta Medica Scandinavica 1978;204(1‐2):81‐4. - PubMed
BNF 2004
    1. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. 3rd Edition. Vol. 48, London: British Medical Association, 2004:456‐7.
Boddy 1968
    1. Boddy K, King P, Mervyn L, Macleod A, Adams JF. Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B 12 after parenteral administration. Lancet 1968;292(7570):710‐2. - PubMed
Boutron 2014
    1. Boutron I, Altman DG, Hopewell S, Vera‐Badillo F, Tannock I, Ravaud P. Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. Journal of Clinical Oncology 2014;32:4120‐6. - PubMed
Brito 2015
    1. Brito A, Mujica‐Coopman MF, López de Romaña D, Cori H, Allen LH. Folate and vitamin B12 status in Latin America and the Caribbean: an update. Food and Nutrition Bulletin 2015;36(Suppl 2):S109‐18. [DOI: 10.1177/0379572115585772] - DOI - PubMed
Castelli 2011
    1. Castelli MC, Friedman K, Sherry J, Brazzillo K, Genoble L, Bhargava P, et al. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open‐label, parallel‐group study. Clinical Therapeutics 2011;33(3):358‐71. - PubMed
Clarke 2004
    1. Clarke R, Grimley Evans J, Schneede J, Nexo E, Bates C, Fletcher A, et al. Vitamin B12 and folate deficiency in later life. Age and Ageing 2004;33:34‐41. - PubMed
De Jager 2010
    1. Jager J, Kooy A, Lehert P, Wulffelé MG, Kolk J, Bets D, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B‐12 deficiency: randomised placebo controlled trial. BMJ 2010;340:c2181. - PMC - PubMed
Elia 1998
    1. Elia M. Oral or parenteral therapy for B12 deficiency. Lancet 1998;352(9142):1721‐2. - PubMed
FAO/WHO 1988
    1. Report of a Joint FAO/WHO Expert Consultation. Requirements of vitamin A, iron, folate and vitamin B12. Report of a Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Series. Vol. 23, Rome: Food and Agriculture Organization of the United Nations; World Health Organization, 1988.
Figlin 2003
    1. Figlin E, Chetrit A, Shahar A, Shpilberg O, Zivelin A, Rosenberg N, et al. High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel. British Journal of Haematology 2003;123:696‐701. - PubMed
Glass 1961
    1. Glass GB, Skeggs HR, Lee DH, Jones EL, Hardy WW. Hydroxocobalamin. I. Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc‐tannate complex. Blood 1961;18:511‐21. - PubMed
Graham 2007
    1. Graham ID, Jette N, Tetroe J, Robinson N, Milne S, Mitchell SL. Oral cobalamin remains medicine's best kept secret. Archives of Gerontology and Geriatrics 2007;44(1):49‐59. - PubMed
Green 2013
    1. Green. Physiology, dietary sources, and requirements. Encyclopedia of Human Nutrition 2013;4:351‐6.
Hall 1977
    1. Hall CA. The carriers of native vitamin B12 in normal human serum. Clinical Science and Molecular Medicine 1977;53:453‐7. - PubMed
Higgins 2002
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2009
    1. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re‐evaluation of random‐effects meta‐analysis. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009;172(1):137‐59. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. - PMC - PubMed
Hozo 2005
    1. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [DOI: 10.1186/1471-2288-5-13] - DOI - PMC - PubMed
Hróbjartsson 2013
    1. Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):E201‐11. - PMC - PubMed
Kirkham 2010
    1. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: 10.1136/bmj.c365] - DOI - PubMed
Lam 2013
    1. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013;310:2435‐42. - PubMed
Lederle 1998
    1. Lederle FA. Oral cobalamin for pernicious anemia: back from the verge of extinction. Journal of the American Geriatrics Society 1998;46:1125‐7. - PubMed
Liberati 2009
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 2009;6(7):1‐28. [DOI: 10.1371/journal.pmed.1000100] - DOI - PMC - PubMed
Lindenbaum 1994
    1. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. American Journal of Clinical Nutrition 1994;60(1):2‐11. - PubMed
MacFarlane 2011
    1. MacFarlane AJ, Greene‐Finestone LS, Shi Y. Vitamin B‐12 and homocysteine status in a folate‐replete population. American Journal of Clinical Nutrition 2011;94(4):1079‐87. - PubMed
Mathieu 2009
    1. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977‐84. - PubMed
Meader 2014
    1. Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3:82. - PMC - PubMed
Middleton 1985
    1. Middleton J, Wells W. Vitamin B12 injections: considerable source of work for the district nurse. BMJ 1985;290(6477):1254‐5. - PMC - PubMed
Nilsson 2005
    1. Nilsson M, Norberg B, Hultdin J, Sandstrom H, Westman G, Lokk J. Medical intelligence in Sweden. Vitamin B12: oral compared with parenteral?. Postgraduate Medical Journal 2005;81:191‐3. - PMC - PubMed
Pawlak 2013
    1. Pawlak R, Parrott SJ, Raj S, Cullum‐Dugan D, Lucus D. How prevalent is vitamin B12 deficiency among vegetarians?. Nutrition Reviews 2013;71(2):110‐7. - PubMed
Pawlak 2015
    1. Pawlak R. Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians?. American Journal of Preventive Medicine 2015;48(6):e11‐26. - PubMed
Pennypacker 1992
    1. Pennypacker LC, Allen RH, Kelly JP, Matthews LM, Grigsby J, Kaye K. High prevalence of cobalamin deficiency in elderly outpatients. Journal of the American Geriatrics Society 1992;40:1197‐204. - PubMed
Quadros 2010
    1. Quadros E. Advances in the understanding of cobalamin assimilation and metabolism. British Journal of Haematology 2010;148:195‐204. - PMC - PubMed
Rajan 2002
    1. Rajan S, Wallace JI, Beresford SA, Brodkin KI, Allen RA, Stabler SP. Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. Journal of the American Geriatrics Society 2002;50(4):624‐30. - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rickes 1948
    1. Rickes EL, Brink NG, Koniuszy FR, Wood TR, Folkers K. Crystalline vitamin B12. Science 1948;107:396. - PubMed
Riley 2011
    1. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta‐analyses. BMJ 2011;342:d549. - PubMed
Schroll 2015
    1. Schroll JB, Bero L. Regulatory agencies hold the key to improving Cochrane Reviews of drugs [editorial]. Cochrane Database of Systematic Reviews 2015; Vol. 4. [DOI: 10.1002/14651858.ED000098] - DOI - PMC - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Smith 1948
    1. Smith EL. Purification of anti‐pernicious anaemia factor from liver. Nature 1948;161:638. - PubMed
Stabler 2013
    1. Stabler SP. Clinical practice. Vitamin B12 deficiency. New England Journal of Medicine 2013;368(2):149‐60. - PubMed
Sterne 2011
    1. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002. - PubMed
van Walraven 1999
    1. Walraven C, Naylor CD. Use of vitamin B12 injections among elderly patients by primary care practitioners in Ontario. Canadian Medical Association Journal 1999;161:146‐9. - PMC - PubMed
Watanabe 2013
    1. Watanabe F, Yabuta Y, Tanioka Y. Biologically active vitamin B12 compounds in foods for preventing deficiency among vegetarians and elderly. Journal of Agricultural and Food Chemistry 2013;61(28):6769‐75. - PubMed
Wong 2006
    1. Wong SSL, Wilczynski NL, Haynes RB. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. Journal of the Medical Library Association 2006;94(1):41‐7. - PMC - PubMed
Wood 2008
    1. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5. - PMC - PubMed

References to other published versions of this review

Vidal‐Alaball 2005
    1. Vidal‐Alaball J, Butler CC, Cannings‐John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004655.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources